Unlock stock picks and a broker-level newsfeed that powers Wall Street.
LSE - Delayed Quote NOK

Aqua Bio Technology ASA (0I8C.L)

Compare
0.5460
-0.0060
(-1.09%)
As of 10:38:43 AM GMT+1. Market Open.
Loading Chart for 0I8C.L
  • Previous Close 0.5520
  • Open 0.5460
  • Bid --
  • Ask --
  • Day's Range 0.5460 - 0.5460
  • 52 Week Range 0.5460 - 4.6496
  • Volume 4,956
  • Avg. Volume 1,900
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) --
  • EPS (TTM) -0.9850
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Oslo, Norway.

aquabiotechnology.com

4

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0I8C.L

View More

Performance Overview: 0I8C.L

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

0I8C.L
0.00%
MSCI WORLD (^990100-USD-STRD)
11.52%

1-Year Return

0I8C.L
0.00%
MSCI WORLD (^990100-USD-STRD)
0.00%

3-Year Return

0I8C.L
88.26%
MSCI WORLD (^990100-USD-STRD)
8.84%

5-Year Return

0I8C.L
88.26%
MSCI WORLD (^990100-USD-STRD)
73.12%

Compare To: 0I8C.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0I8C.L

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.88%

  • Return on Assets (ttm)

    -17.96%

  • Return on Equity (ttm)

    -19.67%

  • Revenue (ttm)

    13.82M

  • Net Income Avi to Common (ttm)

    -1.5M

  • Diluted EPS (ttm)

    -0.9850

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.48M

  • Total Debt/Equity (mrq)

    73.74%

  • Levered Free Cash Flow (ttm)

    -1.92M

Research Analysis: 0I8C.L

View More

Company Insights: 0I8C.L

Research Reports: 0I8C.L

View More

People Also Watch